Classement en actions
#21916
ABIONYX Pharma SA is a biotechnology company dedicated to the identification... ABIONYX Pharma SA is a biotechnology company dedicated to the identification and advancement of therapies for conditions affecting the kidneys and eyes. The firm's pipeline includes CER-001, an innovative negatively-charged lipoprotein particle. This compound is designed to mimic the structural and functional attributes of pre-beta HDL, utilizing human recombinant apoA-I (a natural high-density lipoprotein protein) along with natural phospholipids like sphingomyelin and dipalmitoylphosphatidylglycerol. CER-001 is currently under development for patients recovering from acute coronary syndrome and those with familial primary hypoalphalipoproteinemia. Another key candidate, CER-002, is a specific agonist for peroxisome proliferator-activated receptor delta, targeting cardiovascular and metabolic diseases. Additionally, CER-209 is being developed as a potential treatment for metabolic liver diseases, atherosclerosis, and non-alcoholic steatohepatitis (NASH). ABIONYX maintains strategic partnerships with GTP Biologics and VBI Therapeutics Group for the bioproduction of its bio-HDL in France. Established in 2005, the company operated as Cerenis Therapeutics Holding SA before its rebranding to ABIONYX Pharma SA in August 2019. Its operations are headquartered in Balma, France.
Prix de l'action
$2.32
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$98.03M
Changement (1 jour)
-1.91%
Échange ABIONYX Pharma S.A. (ABNX)
Le prix ABNX avec la capitalisation boursière de B
Capitalisation boursière de ABIONYX Pharma S.A.(ABNX)
Capitalisation boursière: $98.03M
En August 2026, ABIONYX Pharma S.A. a une capitalisation boursière de $98.03M. Cela fait de ABIONYX Pharma S.A. la 21916th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de ABIONYX Pharma S.A. du 2015 au 2026
ABNX par rapport au top 5 des plus populaires stocks
| Prix pour ABNX |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.211T
|
+5,316,238.88%
|
|
|
|
|
$4.547T
|
+4,638,228.81%
|
|
|
|
|
$4.162T
|
+4,246,218.63%
|
|
|
|
|
$3.593T
|
+3,665,058.50%
|
|
|
|
|
$2.793T
|
+2,849,009.38%
|
